SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responsesAshley Burton(University of Portland), Susan Murray(Oregon Health & Science University)Cellular ImmunologyJanuary 18, 202310.1016/j.cellimm.2023.104674Cited by 6SaveCiteExport RISWatch citationsRelated PapersImmunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells|Leukemia|2020|38